Let Maurice and MFI Characterize Your Vaccine Products
ProteinSimple’s next-gen platforms provide solutions for characterizing vaccine products with speed, accuracy, and reliability, so you can get safe, effective products to market, faster.
Maurice, our automated capillary electrophoresis (CE) platform, combines imaged capillary isoelectric focusing (icIEF) and capillary electrophoresis sodium dodecyl sulfate (CE-SDS) detection modes in one compact, easy-to-use instrument. With Maurice, you get reproducible, high-quality data to get charge heterogeneity, purity, and identity of proteins and delivery vectors for vaccines, such as lipid nanoparticles for mRNA vaccines, as seen in those approved for market for COVID-19.
Micro-Flow Imaging (MFI), accurately and precisely detects subvisible particles in solution, enabling direct detection of aggregates and contaminants in vaccine products, which can be critical for ensuring safety and efficacy. The MFI 5000 series can be automated with our Bot1 autosampler, enabling walk-away time, freeing you to deal with more important tasks.
ANALYTICAL TOOLS FOR THE FIGHT AGAINST COVID-19
The emergence of COVID-19 and the ensuing pandemic has meant that safe, fast, and effective vaccine development has never been more critical. View this webinar to learn about the analytical platforms that ProteinSimple has to offer to arm researchers with the tools needed to combat this virus.
ANALYTICAL SOLUTIONS FOR VACCINE DEVELOPMENT
Learn how researchers at Merck and Medgene use Maurice and other ProteinSimple platforms to assess proteins used in vaccine development for critical quality attributes such as identity and purity, in this on-demand webinar.
Characterization of LNPs with Maurice
OTHER RELATED VACCINE DEVELOPMENT LINKS
Vaccine Research and Development Workflow
CE-SDS Analysis Method Benefits with Maurice
Cancer Immunotherapy Vaccine Monitoring